Copied to clipboard!

Prediction of benefit from adjuvant dose-dense chemotherapy for high-risk breast cancer: results from the randomized phase III PANTHER trial

This study investigates molecular biomarkers associated with benefit from adjuvant dose-dense chemotherapy in patients with high-risk early breast cancer enrolled in the randomized phase III PANTHER trial. RNA sequencing data from tumour samples were used for transcriptomic analyses and biomarker evaluation. The deposited dataset comprises raw RNA-seq FASTQ files and is made available under controlled access.

Type: RNASeq
Archive: European Genome-phenome Archive (EGA)

1 Dataset

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD50000003186	Raw RNA-sequencing data from primary breast cancer tumour samples collected in the randomized phase III PANTHER trial.	Illumina NovaSeq X Plus	444